RIX7 Antibody

What is RIX7 and why is it significant in ribosome biogenesis research?

RIX7 is an essential AAA-type ATPase required for the formation of the large (60S) ribosomal subunit. It belongs to the AAA+ (ATPases Associated with various cellular Activities) superfamily and functions as a molecular unfoldase that powers the progression of ribosome biogenesis by removing specific assembly factors from pre-60S ribosomal particles . RIX7 is structurally composed of three domains: an N-terminal domain (NTD) and two AAA+ domains (D1 and D2) that assemble into an asymmetric stacked hexamer . The protein is critical in early stages of ribosome biogenesis, particularly in the release of the essential assembly factor Nsa1 from nucleolar pre-60S particles, triggering further maturation steps . Its mammalian homolog, NVL2, has been linked to cancer and mental disorders, highlighting the broader significance of understanding RIX7 function .

What are the recommended approaches for detecting RIX7 in yeast cell lysates?

For optimal detection of RIX7 in yeast cell lysates, a multi-step approach is recommended:

• Sample preparation: Extract cell lysates under native conditions using buffer containing 50 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM MgCl₂, 5% glycerol, and 0.5 mM DTT to preserve protein structure and interactions .

• Fractionation: Consider using sucrose gradient centrifugation to separate different ribosomal assembly intermediates, as RIX7 associates with specific pre-ribosomal particles, particularly the Nsa1-containing particles .

• Western blotting: Use denaturing SDS-PAGE followed by transfer to appropriate membranes. For RIX7 detection, primary antibodies against RIX7 followed by species-appropriate HRP-conjugated secondary antibodies (such as anti-rat IgG HRP if using rat-derived primary antibodies) provide robust results .

• Controls: Include both negative controls (e.g., rix7Δ strains complemented with plasmid-based expression) and positive controls (e.g., RIX7-GFP tagged strains for dual detection strategies) .

How can I distinguish between nucleolar and nucleoplasmic localization of RIX7?

Distinguishing between nucleolar and nucleoplasmic localization of RIX7 requires careful experimental design:

• Fluorescence microscopy optimization: When using RIX7-GFP fusions, optimize exposure settings (0.2-0.3s exposure, 25-50% transmission, 3 Z-planes is recommended based on published protocols) .

• Cell growth phase considerations: RIX7 exhibits distinct localization patterns depending on growth phase - throughout the nucleus in exponentially growing cells but concentrated in the nucleolus in stationary phase cells . Document growth conditions precisely.

• Co-localization markers: Use established nucleolar markers (such as Nop1) and nucleoplasmic markers (such as Rix1) as references in co-localization experiments .

• Temperature-sensitive mutants: Utilize temperature-sensitive rix7 mutants like rix7-1, which shows predominantly nucleolar accumulation of Rpl25-GFP reporter at restrictive temperatures .

• Time-lapse imaging: For dynamic studies, consider time-lapse microscopy (intervals of 120-180s) to capture RIX7 relocalization, particularly during transitions between growth phases .

What are the best strategies for studying RIX7 interaction with its substrate proteins?

To effectively study RIX7 interactions with substrate proteins, several complementary approaches are recommended:

• Cross-linking mass spectrometry (XL-MS): Use BS3 (bis(sulfosuccinimidyl) suberate) cross-linking at optimized concentrations (approximately 19 μM BS3 for 3 μM hexameric RIX7) followed by SEC purification and mass spectrometry analysis . This approach can reveal both inter-domain and intra-domain interactions.

• Cryo-EM structural analysis: For detailed interaction studies, utilize Walker B mutants (E303Q and/or E602Q in Chaetomium thermophilum Rix7) to stabilize substrate-bound complexes for structural analysis at high resolution (2.9-4.5Å) .

• Genetic interaction studies: Synthetic lethal screens with rix7 alleles affecting the N-terminal domain can identify functionally relevant interactors. Previous studies identified synthetic lethality between rix7-1 and rpl10-2 alleles, indicating functional interaction between Rix7p and Rpl10p .

• Co-immunoprecipitation assays: Use TAP-tagged potential substrate proteins (such as Nsa1-TAP) for pull-downs and analyze RIX7 co-enrichment by western blotting. Include controls with other TAP-tagged bait proteins representing different pre-60S particles (e.g., Nop7, Ssf1, Rix1, Arx1, and Kre35) .

How should RIX7 antibody specificity be validated for ribosome biogenesis studies?

Validating RIX7 antibody specificity for ribosome biogenesis studies requires rigorous controls:

• Expression system validation: Test antibodies against recombinant RIX7 protein expressed in bacterial systems (E. coli) alongside wild-type and rix7 mutant yeast extracts to confirm specificity .

• Domain-specific detection: Validate antibodies against truncated RIX7 variants (ΔNTD, D1-only, D2-only constructs) to confirm epitope specificity, particularly important when studying domain-specific functions .

• Competition assays: Perform antibody pre-absorption with purified recombinant RIX7 to demonstrate specific binding.

• Cross-reactivity assessment: Test for cross-reactivity with related AAA-ATPases, particularly Cdc48, which is the closest yeast homologue to RIX7 , using western blot analysis of purified proteins.

• Genetic validation: Use RIX7-deficient or RIX7-depleted cells (utilizing degron-tagged RIX7 constructs) as negative controls to confirm signal specificity.

What methods are most effective for analyzing RIX7's role in pre-rRNA processing?

To effectively analyze RIX7's role in pre-rRNA processing, implement the following methodological approaches:

• Pulse-chase labeling: Use [³H]uracil or [³H]methyl methionine labeling followed by denaturing gel electrophoresis to monitor pre-rRNA processing kinetics. This approach revealed that rix7-1 mutants show dramatic reduction in synthesis of both 25S and 5.8S rRNAs at restrictive temperature .

• Northern blot analysis: Employ specific probes to detect 27SA, 27SB, and 7S pre-rRNAs, focusing on the 27SB pre-rRNA which is notably destabilized in rix7 mutants .

• Sucrose gradient fractionation: Analyze ribosomal profiles using sucrose gradient centrifugation under both low and high salt conditions to assess the integrity of pre-60S particles .

• Temperature-shift experiments: For temperature-sensitive rix7 alleles, perform time-course analyses after shift to restrictive temperature to capture immediate effects on pre-rRNA processing before secondary consequences of growth arrest appear (optimal timepoint is around 2-3 hours post-shift) .

• Coimmunoprecipitation of pre-rRNAs: Use RIX7 antibodies to immunoprecipitate RIX7-containing complexes and analyze associated pre-rRNAs to determine direct interactions with specific pre-rRNA species.

How should experiments be designed to distinguish direct and indirect effects of RIX7 disruption?

Distinguishing direct and indirect effects of RIX7 disruption requires careful experimental design:

• Rapid depletion systems: Utilize auxin-inducible or tetracycline-regulatable degron systems rather than gene deletion to observe immediate consequences of RIX7 depletion before secondary effects manifest.

• Time-resolved analysis: Perform time-course analyses after RIX7 inactivation, focusing on early timepoints. For example, in rix7-1 mutants, nuclear accumulation of Rpl25p-eGFP becomes visible 2-3 hours after temperature shift, before distinct growth defects appear .

• Domain-specific mutations: Engineer mutations in specific functional domains rather than disrupting the entire protein. Mutations in Walker B motifs (E303Q, E602Q) affect ATP hydrolysis without completely inactivating the protein .

• Substrate-binding trap mutants: Use Walker B mutants that can bind but not release substrates to identify direct RIX7 interaction partners .

• Suppressor screens: Identify genetic suppressors of rix7 mutants to map functional pathways and distinguish primary from secondary effects.

What are the critical parameters for successful purification of functional RIX7 protein for in vitro studies?

Successful purification of functional RIX7 protein requires careful attention to these parameters:

For additional stability when working with wild-type RIX7, consider using Walker B mutations (E303Q and/or E602Q) which significantly improve protein stability by slowing ATP hydrolysis and stabilizing the hexameric assembly .

How can researchers effectively analyze the dynamic cellular localization of RIX7?

To effectively analyze RIX7's dynamic cellular localization:

• Live-cell imaging optimization: For RIX7-GFP imaging in exponentially growing cells, use: 120s intervals, 0.2s exposure, 25% transmission, 3 Z-planes, 100× oil objective. For stationary cultures, adjust to: 180s intervals, 0.3s exposure, 50% transmission, 3 Z-planes, 100× oil objective .

• Growth phase transitions: Design experiments to capture RIX7 relocalization during transitions between growth phases, particularly when cells resume growth after stationary phase, when RIX7 exhibits a transient perinuclear location .

• Fixation techniques: If using fixed samples, optimize fixation protocols (4% paraformaldehyde, 12 minutes, room temperature) to preserve nuclear architecture while maintaining antibody accessibility.

• Quantitative analysis: Implement quantitative image analysis to measure nuclear/nucleolar fluorescence intensity ratios across different conditions and timepoints.

• Co-localization with nuclear landmarks: Perform simultaneous visualization of RIX7 with nucleolar markers (such as Nop1) and nuclear envelope markers (such as Nup proteins) to precisely map relocalization events .

How should researchers interpret RIX7 antibody signals in different subcellular fractions?

When interpreting RIX7 antibody signals across subcellular fractions, consider these analytical guidelines:

• Fractionation quality control: Always validate nuclear/nucleolar/cytoplasmic fractionation using established markers for each compartment (e.g., Nop1 for nucleolus, Rix1 for nucleoplasm) .

• Hexamer versus monomer detection: RIX7 can exist in different oligomeric states depending on cellular conditions. Under native conditions (without SDS), antibodies may detect predominantly hexameric forms (~550 kDa) which should be distinguished from monomeric RIX7 (~92 kDa) .

• Growth phase considerations: Interpret fractionation results in context of growth phase, as RIX7 localizes throughout the nucleus in exponentially growing cells but concentrates in the nucleolus in stationary phase .

• Signal in pre-ribosomal particles: In pre-60S particle purifications, RIX7 is strongly enriched specifically in Nsa1-containing particles but largely absent from other pre-60S particles (with exception of early Nop7-containing particles) . Unexpected signals in other particles may indicate experimental artifacts.

• Detection in mutant backgrounds: In certain ribosome assembly factor mutants, RIX7 distribution may change, reflecting its dynamic association with evolving pre-60S particles.

What approaches can resolve discrepancies between structural and functional data on RIX7?

To resolve discrepancies between structural and functional data on RIX7:

• Structure-guided mutagenesis: Design point mutations in key structural features identified in cryo-EM studies (such as pore loops, ISS motifs, and the D1-D2 linker) and assess their functional consequences in vivo .

• Domain swap experiments: Create chimeric proteins with domains from related AAA-ATPases to determine which structural features confer RIX7-specific functions.

• Correlation of nucleotide states: Compare ATP/ADP occupancy observed in structural studies with ATPase activity measurements to connect structural snapshots with the functional cycle .

• Substrate-engaged structures: Compare apo and substrate-engaged structures to understand conformational changes during the functional cycle. The recent cryo-EM structures of RIX7 with polypeptide substrates in the central channel provide crucial insights into its unfoldase mechanism .

• Integration of dynamic data: Complement static structural information with hydrogen-deuterium exchange mass spectrometry (HDX-MS) or single-molecule FRET to capture dynamics not evident in cryo-EM snapshots.

How can researchers differentiate between direct RIX7 substrates and secondary effects in ribosome biogenesis?

To differentiate direct RIX7 substrates from secondary effects in ribosome biogenesis:

• Substrate-trapping variants: Utilize Walker B mutants (E303Q/E602Q) that can bind but not release substrates, allowing identification of direct interaction partners .

• Cross-linking mass spectrometry (XL-MS): Optimize cross-linking conditions (e.g., 19 μM BS3 for 3 μM hexameric RIX7) to capture transient interactions between RIX7 and potential substrates .

• Temporal analysis of phenotypes: Implement time-resolved analyses after RIX7 inactivation to distinguish immediate consequences (likely direct effects) from delayed phenotypes (likely secondary effects).

• Correlation with structural data: Examine whether potential substrates can be accommodated in the central channel of RIX7 based on structural constraints from cryo-EM data .

• Genetic bypass experiments: Test whether constitutive removal or depletion of proposed substrate proteins can bypass RIX7 requirement, which would strongly support a direct substrate relationship.

What are the most informative experimental controls for RIX7 antibody validation?

For comprehensive RIX7 antibody validation, implement these essential controls:

• Genetic controls: Test antibodies against:

  • Wild-type yeast extracts

  • rix7Δ strains complemented with plasmid-based RIX7 (positive control)

  • rix7Δ strains with empty vector (negative control)

  • rix7 temperature-sensitive mutants at permissive and restrictive temperatures

• Structural variant controls: Validate against:

  • Full-length RIX7

  • N-terminal domain deletion (ΔNTD-RIX7)

  • Individual AAA domains (D1 or D2 only)

  • Walker B mutants (E303Q, E602Q, and E303Q/E602Q double mutant)

• Cross-reactivity assessment: Test against related AAA-ATPases, particularly:

  • Cdc48 (closest yeast homolog)

  • Rea1 and Drg1 (other AAA-ATPases involved in ribosome biogenesis)

• Pre-absorption control: Pre-incubate antibody with purified recombinant RIX7 protein before use in applications to confirm signal specificity.

• Epitope mapping: Determine precise epitope recognition using peptide arrays or truncated protein variants to ensure antibody recognizes relevant conformational states.

How might RIX7 antibodies contribute to understanding the link between ribosome biogenesis and disease?

RIX7 antibodies can provide valuable insights into disease mechanisms through these research approaches:

• Cancer research applications: RIX7's mammalian homolog NVL2 has been linked to cancer . Use validated antibodies to:

  • Compare NVL2/RIX7 expression levels and localization patterns in normal versus cancer cells

  • Evaluate changes in substrate processing efficiency in disease contexts

  • Identify alterations in protein-protein interaction networks in malignant cells

• Neurodevelopmental disorder research: Given NVL2's links to mental illness disorders , investigate:

  • Developmental expression patterns of RIX7/NVL2 in neuronal tissues

  • Altered substrate processing in patient-derived cells

  • Impact of disease-associated mutations on RIX7/NVL2 localization and function

• Ribosomopathies: For disorders caused by ribosome biogenesis defects, examine:

  • Whether RIX7/NVL2 function is compromised

  • If disease-associated mutations affect RIX7/NVL2-dependent steps

  • Potential for manipulating RIX7/NVL2 activity as therapeutic approach

• Stress response pathways: Investigate how cellular stresses affect:

  • RIX7/NVL2 expression, localization, and substrate targeting

  • Integration of ribosome biogenesis with stress signaling pathways

What novel methodologies might enhance the study of RIX7's role in coordinating ribosome biogenesis?

Emerging methodologies with potential to advance RIX7 research include:

• Proximity labeling approaches: Implement BioID or APEX2 fusion proteins to identify proteins in close proximity to RIX7 in living cells, capturing transient interactions missed by conventional co-IP approaches.

• Single-molecule approaches: Apply techniques such as:

  • Single-molecule FRET to monitor conformational changes during ATP hydrolysis cycle

  • Optical tweezers to directly measure force generation during substrate processing

• Cryo-electron tomography: Visualize RIX7 in its native cellular context within pre-ribosomes, providing insights into spatial organization and substrate targeting in situ.

• Integrative structural biology: Combine cryo-EM, cross-linking mass spectrometry, and computational modeling to build comprehensive models of RIX7-substrate complexes in different functional states .

• High-throughput genetic interaction mapping: Employ CRISPR-based screens to systematically map genetic interactions, identifying new functional connections between RIX7 and other cellular pathways.

How can researchers effectively study the coordination between RIX7 and other AAA-ATPases in ribosome biogenesis?

To effectively study coordination between RIX7 and other ribosome biogenesis AAA-ATPases:

• Sequential depletion experiments: Implement systems for rapid, sequential depletion of multiple AAA-ATPases (RIX7, Rea1, Drg1) to determine hierarchical relationships.

• Substrate handover analysis: Track the fate of specific substrates as they progress through multiple AAA-ATPase processing steps using fluorescently tagged substrates or pulse-chase approaches.

• Assembly intermediate accumulation: Quantitatively analyze pre-ribosomal particles that accumulate upon inactivation of each AAA-ATPase to establish the precise order of action.

• Unified structural analysis: Compare substrate engagement mechanisms across different ribosome biogenesis AAA-ATPases using consistent structural biology approaches .

• Integrated timeline construction: Combine data from multiple sources to construct comprehensive timelines of AAA-ATPase action during ribosome maturation, incorporating information on:

  • Pre-rRNA processing status

  • Assembly factor association/dissociation kinetics

  • Nucleolar/nucleoplasmic/cytoplasmic transitions

  • ATP hydrolysis coupling to structural rearrangements